R

Active Director Director DIN 09285829
DIN 09285829 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Rashmi

Data last updated:

Rashmi is a Director at Nephro Medishield Private Limited (since 2021). The company operates in Healthcare. Nephro Medishield Private Limited reported revenue of ₹5.3 Lakh (FY 2025).

DIN 09285829
Primary Designation Director
Industry Healthcare
First Appointment 18 Aug 2021
Oldest Company Age 5 yrs
Largest company Nephro Medishield Private Limited · ₹5.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nephro Medishield Private Limited U85100DL2021PTC385320
Director18 Aug 20212021₹5.3 Lakh (FY 2025)Active

Board colleagues of Rashmi

NameDINCompanyDesignation
Gayatri Mishra09285828Nephro Medishield Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nephro Medishield Private Limited
Premium access

Shareholding and investment profile for Rashmi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmi

Rashmi currently holds 1 directorship: Nephro Medishield Private Limited (Director, since 18 Aug 2021, revenue ₹5.3 Lakh (FY 2025)).

Rashmi was first appointed on 18 Aug 2021 as Director at Nephro Medishield Private Limited.

The current boards of Rashmi's companies include Gayatri Mishra (Nephro Medishield Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available